- 23373528OWN - NLMSTAT- MEDLINEDA  - 20130305DCOM- 20130816IS  - 1525-1594 (Electronic)IS  - 0160-564X (Linking)VI  - 37IP  - 3DP  - 2013 MarTI  - Thrombolysis for suspected intrapump thrombosis in patients with continuous flow       centrifugal left ventricular assist device.PG  - 313-8LID - 10.1111/j.1525-1594.2012.01567.x [doi]AB  - The current recommended anticoagulation regimen during continuous flow      centrifugal left ventricular device support is a combination of antiplatelet      therapy as well as oral anticoagulation. Despite this, pump thrombosis occurs in       rare situations. We report the risk factors and nonsurgical management and      outcomes of five patients implanted with continuous flow centrifugal left      ventricular assist devices who displayed clinical, hemodynamic, and laboratory      features of intrapump thrombosis. This information may support the use of      intravenous thrombolytics for suspected pump thrombus in these newer generation      devices.CI  - (c) 2013, Copyright the Authors. Artificial Organs (c) 2013, International Center      for Artificial Organs and Transplantation and Wiley Periodicals, Inc.FAU - Muthiah, KavithaAU  - Muthiah KAD  - Heart Failure and Transplant Unit, Failure and Transplant Unit, St. Vincent\s      Hospital, Victoria St., Darlinghurst, Sydney, NSW 2010, Australia.FAU - Robson, DesireeAU  - Robson DFAU - Macdonald, Peter SAU  - Macdonald PSFAU - Keogh, Anne MAU  - Keogh AMFAU - Kotlyar, EugeneAU  - Kotlyar EFAU - Granger, EmilyAU  - Granger EFAU - Dhital, KumudAU  - Dhital KFAU - Spratt, PhillipAU  - Spratt PFAU - Jansz, PaulAU  - Jansz PFAU - Hayward, Christopher SAU  - Hayward CSLA  - engPT  - Case ReportsPT  - Journal ArticleDEP - 20130204PL  - United StatesTA  - Artif OrgansJT  - Artificial organsJID - 7802778RN  - 0 (Anticoagulants)RN  - 0 (Fibrinolytic Agents)RN  - 0 (Platelet Aggregation Inhibitors)SB  - IMMH  - AdultMH  - Anticoagulants/therapeutic useMH  - Fatal OutcomeMH  - FemaleMH  - Fibrinolytic Agents/*administration & dosageMH  - Heart Failure/diagnosis/physiopathology/*therapyMH  - Heart TransplantationMH  - Heart-Assist Devices/*adverse effectsMH  - HemodynamicsMH  - HemolysisMH  - HumansMH  - MaleMH  - Middle AgedMH  - Platelet Aggregation Inhibitors/therapeutic useMH  - Prosthesis DesignMH  - Prosthesis FailureMH  - Risk FactorsMH  - *Thrombolytic TherapyMH  - Thrombosis/blood/diagnosis/*drug therapy/etiologyMH  - Time FactorsMH  - Treatment OutcomeMH  - *Ventricular Function, LeftEDAT- 2013/02/05 06:00MHDA- 2013/08/21 06:00CRDT- 2013/02/05 06:00PHST- 2013/02/04 [aheadofprint]AID - 10.1111/j.1525-1594.2012.01567.x [doi]PST - ppublishSO  - Artif Organs. 2013 Mar;37(3):313-8. doi: 10.1111/j.1525-1594.2012.01567.x. Epub      2013 Feb 4.- 23373528own - nlmstat- medlineda  - 20130305dcom- 20130816is  - 1525-1594 (electronic)is  - 0160-564x (linking)vi  - 37ip  - 3dp  - 2013 marti  - thrombolysis for suspected intrapump thrombosis in patients with continuous flow       centrifugal left ventricular assist device.pg  - 313-8lid - 10.1111/j.1525-1594.2012.01567.x [doi]ab  - the current recommended anticoagulation regimen during continuous flow      centrifugal left ventricular device support is a combination of antiplatelet      therapy as well as oral anticoagulation. despite this, pump thrombosis occurs in       rare situations. we report the risk factors and nonsurgical management and      outcomes of five patients implanted with continuous flow centrifugal left      ventricular assist devices who displayed clinical, hemodynamic, and laboratory      features of intrapump thrombosis. this information may support the use of      intravenous thrombolytics for suspected pump thrombus in these newer generation      devices.ci  - (c) 2013, copyright the authors. artificial organs (c) 2013, international center      for artificial organs and transplantation and wiley periodicals, inc.fau - muthiah, kavithaau  - muthiah kad  - heart failure and transplant unit, failure and transplant unit, st. vincent\s      hospital, victoria st., darlinghurst, sydney, nsw 2010, australia.fau - robson, desireeau  - robson dfau - macdonald, peter sau  - macdonald psfau - keogh, anne mau  - keogh amfau - kotlyar, eugeneau  - kotlyar efau - granger, emilyau  - granger efau - dhital, kumudau  - dhital kfau - spratt, phillipau  - spratt pfau - jansz, paulau  - jansz pfau - hayward, christopher sau  - hayward csla  - engpt  - case reportspt  - journal articledep - 20130204pl  - united statesta  - artif organsjt  - artificial organsjid - 7802778rn  - 0 (anticoagulants)rn  - 0 (fibrinolytic agents)rn  - 0 (platelet aggregation inhibitors)sb  - immh  - adultmh  - anticoagulants/therapeutic usemh  - fatal outcomemh  - femalemh  - fibrinolytic agents/*administration & dosagemh  - heart failure/diagnosis/physiopathology/*therapymh  - heart transplantationmh  - heart-assist devices/*adverse effectsmh  - hemodynamicsmh  - hemolysismh  - humansmh  - malemh  - middle agedmh  - platelet aggregation inhibitors/therapeutic usemh  - prosthesis designmh  - prosthesis failuremh  - risk factorsmh  - *thrombolytic therapymh  - thrombosis/blood/diagnosis/*drug therapy/etiologymh  - time factorsmh  - treatment outcomemh  - *ventricular function, leftedat- 2013/02/05 06:00mhda- 2013/08/21 06:00crdt- 2013/02/05 06:00phst- 2013/02/04 [aheadofprint]aid - 10.1111/j.1525-1594.2012.01567.x [doi]pst - ppublishso  - artif organs. 2013 mar;37(3):313-8. doi: 10.1111/j.1525-1594.2012.01567.x. epub      2013 feb 4.